This resolution supports the designation of National Bladder Cancer Awareness Month.
[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 415 Introduced in House (IH)]
<DOC>
118th CONGRESS
1st Session
H. RES. 415
Expressing support for the designation of May as ``National Bladder
Cancer Awareness Month''.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
May 17, 2023
Mr. Cartwright (for himself, Mr. Aderholt, Ms. Barragan, Ms. Clarke of
New York, Mr. Cleaver, Mr. Connolly, Mr. Davis of North Carolina, Mr.
Fitzpatrick, Mr. Grijalva, Mr. Krishnamoorthi, Ms. Norton, Mr. Payne,
Ms. Porter, Mr. Ruiz, Mr. David Scott of Georgia, Ms. Sewell, Mr.
Tonko, Mrs. Trahan, and Ms. Wild) submitted the following resolution;
which was referred to the Committee on Energy and Commerce
_______________________________________________________________________
RESOLUTION
Expressing support for the designation of May as ``National Bladder
Cancer Awareness Month''.
Whereas increased public awareness and early treatment of bladder cancer will
save thousands of lives;
Whereas more than 800,000 families in the United States live with bladder
cancer;
Whereas it is estimated that more than 82,290 people in the United States, or
over 230 Americans every day, will be diagnosed with bladder cancer in
2023, including over 62,420 men and 19,870 women;
Whereas it is estimated that bladder cancer will kill more than 16,710 Americans
this year alone;
Whereas the bladder cancer diagnosis rate is expected to increase by 1.35
percent in 2023, while many other forms of cancer are projected to
decline;
Whereas bladder cancer can directly impact all people, regardless of age, sex,
and race;
Whereas bladder cancer is among the top 7 most diagnosed cancers in the United
States, and the top 4 most commonly diagnosed cancers for our honored
veterans;
Whereas, if diagnosed early, bladder cancer is highly treatable, but
survivability rates decrease substantially with later detection;
Whereas smoking and environmental or occupational exposure to carcinomic
chemicals are the top causes of bladder cancer;
Whereas studies have shown a higher level of bladder cancer in firefighters,
veterans, and senior citizens than in the general public;
Whereas bladder cancer symptoms, such as blood in the urine, are easily
recognized, however, many Americans are unaware of the warning signs and
often put off diagnostic testing and treatment;
Whereas bladder cancer is known as one of the most expensive cancers to treat on
a per patient basis and has a reoccurrence rate of approximately 50 to
80 percent, requiring lifelong surveillance;
Whereas, while bladder cancer is more prevalent in men, women are commonly
diagnosed at a later stage and face a worse prognosis even when
diagnosed at the same stage as men;
Whereas there have been limited significant breakthroughs in the past 30 years
to advance the treatment of and move toward a cure for bladder cancer;
Whereas the quality of life and chance of survival for a bladder cancer patient
depends largely on new advancements and a renewed focus on research from
both the Federal Government and private industry;
Whereas increased awareness for bladder cancer will promote earlier diagnosis
and increased chances of survival;
Whereas, in 2023, Congress will require the Department of Veterans Affairs to
dramatically increase bladder cancer treatments for the Nation's
veterans, living up to the promise the Nation made decades ago;
Whereas based on the Nation's experience diagnosing and caring for Vietnam
veterans exposed to carcinogenic chemicals such as Agent Orange and
Agent Blue, efforts are underway to document current servicemembers'
exposure to burn pits;
Whereas the Congressionally Directed Medical Research Programs, working
concurrently with the National Institutes of Health, annually fund the
high-risk, high-reward, research required to one day discover a cure for
bladder cancer;
Whereas traditionally throughout May, survivors, caregivers, and loved ones
unite for walks in communities across the United States to raise
awareness for bladder cancer along with funds for bladder cancer
research;
Whereas the Bladder Cancer Advocacy Network has worked for more than 18 years to
raise public awareness for bladder cancer while providing patients with
the knowledge, resources, and support they need to navigate their
personal bladder cancer journey;
Whereas the Bladder Cancer Advocacy Network annually funds cutting edge research
in search of better treatments and a final cure for bladder cancer while
working every day to raise public awareness, support patients, and
increase research; and
Whereas May would be an appropriate month to designate as ``National Bladder
Cancer Awareness Month'': Now, therefore, be it
Resolved, That the House of Representatives--
(1) supports the designation of ``National Bladder Cancer
Awareness Month'';
(2) supports the goals and ideals of ``National Bladder
Cancer Awareness Month''; and
(3) calls on the people of the United States, interested
groups, the research community, and affected persons to--
(A) promote awareness of bladder cancer and foster
understanding of the impact of the disease on patients,
their families, caregivers, and their community;
(B) take an active role in the fight to end bladder
cancer; and
(C) observe ``National Bladder Cancer Awareness
Month'' with appropriate ceremonies and activities.
<all>
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line